SYTL1 and neoplasm: The results demonstrated that high SYTL1 expression was obviously associated with good prognosis in EC patients Stage I&Stage II (p = 0.002), Histologic grade G3 (p = 0.003), Tumor invasion < 50% (p = 0.023) and Tumor invasion > = 50% (p = 0.002), and the expression of SYTL1 was not significantly related with prognosis in EC patients Stage III&Stage IV (p = 0.411), histologic grade G1 (p = 0.956), and histologic grade G2 (p = 0.397).